Management Team

Brian Mooney, MBA

Chief Financial Officer

Brian Mooney has over 25 years of senior management experience in life sciences, software, and financial industries both as a Chief Financial Officer and Chief Operating Officer. Brian brings broad experience in venture capital and mergers & acquisitions, having been a Managing Partner of a venture lending fund and a boutique merchant bank. He has successfully structured and closed a wide variety of transactions and served on multiple boards of directors. Brian has also managed a wholly owned subsidiary of a publicly traded company and been in charge of subsidiary reporting. Brian received a BA in Finance from Trinity College Dublin and an MBA from Smith School of Business, University of Maryland.

Erin Mitchell, PhD

Senior Vice President, Manufacturing

Erin Mitchell has extensive experience in process development and manufacturing. As Director of Manufacturing and Process Development at MediGene, Erin assembled and directed a team of scientists and technicians that developed a scalable manufacturing process for herpes virus. Previously, she was a key part of the team that developed the process and oversaw the successful production of the material used for the Phase 1 clinical trial of NeuroVir’s herpes virus product. Erin received a BS in Biochemistry from McMaster University, an MSc in Biochemistry from The University of Toronto, and a PhD in Immunology from Cambridge University.

Joan Robbins, PhD

vice president, Translational research

Joan Robbins has comprehensive experience in the development of gene therapy. Prior to joining DNAtrix, Joan served as Senior Vice President of Biosafety & Gene Therapy at Western Institutional Review Board (WIRB) - Copernicus Group, the world’s largest provider of regulatory and ethical review for human research. Prior to that she was Vice President of Translational Research at Tocagen, advancing the first replicating retroviral vector from the bench to a pivotal study in primary brain cancer. She also served as CSO of ADVENTRX Pharmaceuticals, developing a portfolio of drugs for cancer and infectious disease, and was VP of Product Development at Immusol, developing gene therapies and biologics for multiple indications. Additionally, Joan is the co- founder of two virus and biologic specialty manufacturing companies. Joan trained at the NIH/NCI, the Garvan Institute and Center for Immunology (Sydney, Australia), and the University of California, San Diego. She received a BS in Genetics from the University of California, Davis, and a PhD in Genetics from the George Washington University, Washington, D.C.